BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27599384)

  • 1. Metabolic syndrome and its individual components with mortality among patients with coronary heart disease.
    Chen Q; Zhang Y; Ding D; Li D; Xia M; Li X; Yang Y; Li Q; Hu G; Ling W
    Int J Cardiol; 2016 Dec; 224():8-14. PubMed ID: 27599384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
    Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
    J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men.
    Vega GL; Barlow CE; Grundy SM; Leonard D; DeFina LF
    J Investig Med; 2014 Feb; 62(2):345-9. PubMed ID: 24402298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual role of physical workload and occupational noise in the association of the metabolic syndrome with risk of coronary heart disease: findings from the Helsinki Heart Study.
    Koskinen HL; Kauppinen T; Tenkanen L
    Occup Environ Med; 2011 Sep; 68(9):666-73. PubMed ID: 21148595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic syndrome: prevalence, risk factors and mortality in a French population of 62 000 subjects].
    Guize L; Thomas F; Pannier B; Bean K; Danchin N; Bénétos A
    Bull Acad Natl Med; 2006 Mar; 190(3):685-97; discussion 697-700. PubMed ID: 17140103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women.
    Zabetian A; Hadaegh F; Azizi F
    Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):525-31. PubMed ID: 18523915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: a matched cohort study.
    Esteghamati A; Hafezi-Nejad N; Sheikhbahaei S; Heidari B; Zandieh A; Ebadi M; Nakhjavani M
    J Clin Lipidol; 2014; 8(3):279-86. PubMed ID: 24793349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Associations between Triglycerides and Metabolic Syndrome Components in a Beijing Adult Population, 2007-2012.
    Tao LX; Yang K; Liu XT; Cao K; Zhu HP; Luo YX; Guo J; Wu LJ; Li X; Guo XH
    Int J Med Sci; 2016; 13(6):445-50. PubMed ID: 27279794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.
    Jackson KG; Walden CM; Murray P; Smith AM; Minihane AM; Lovegrove JA; Williams CM
    Metabolism; 2013 Aug; 62(8):1065-9. PubMed ID: 23598085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between triglyceride/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization.
    Wan K; Zhao J; Huang H; Zhang Q; Chen X; Zeng Z; Zhang L; Chen Y
    PLoS One; 2015; 10(4):e0123521. PubMed ID: 25880982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
    J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate to High Levels of Cardiorespiratory Fitness Attenuate the Effects of Triglyceride to High-Density Lipoprotein Cholesterol Ratio on Coronary Heart Disease Mortality in Men.
    Farrell SW; Finley CE; Barlow CE; Willis BL; DeFina LF; Haskell WL; Vega GL
    Mayo Clin Proc; 2017 Dec; 92(12):1763-1771. PubMed ID: 29157534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study.
    Deedwania PC; Shepherd J; Breazna A; DeMicco DA;
    Diabetes Obes Metab; 2016 Jan; 18(1):56-63. PubMed ID: 26434404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abdominal obesity is the most significant metabolic syndrome component predictive of cardiovascular events in chronic hemodialysis patients.
    Wu CC; Liou HH; Su PF; Chang MY; Wang HH; Chen MJ; Hung SY
    Nephrol Dial Transplant; 2011 Nov; 26(11):3689-95. PubMed ID: 21357211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a Vascular Endothelial Growth Factor genetic variant with Serum VEGF level in subjects with Metabolic Syndrome.
    Ghazizadeh H; Fazilati M; Pasdar A; Avan A; Tayefi M; Ghasemi F; Mehramiz M; Mirhafez SR; Ferns GA; Azimi-Nezhad M; Ghayour-Mobarhan M
    Gene; 2017 Jan; 598():27-31. PubMed ID: 27984191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
    Lim HS; Lip GY; Beevers DG; Blann AD
    Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.